ELIGIBILITY & COST
CDPATH is being offered free of charge for eligible patients1
As part of the program, the costs of CDPATH* will be covered as long as patients meet the following eligibility criteria1:
Adult Crohn's disease patients (≥18 years old) diagnosed within the last 10 years
Patients on a commercial healthcare plan or uninsured†
Patients who have not experienced serious Crohn's disease complications, defined as bowel stricture, internal penetrating disease, or non-perianal surgery (bowel resection or stricturoplasty)
Blood draw taken at participating location
*The CDPATH risk assessment tool was developed and validated by Prometheus Laboratories Inc., a partner of Takeda, and has received conditional approval from the New York State Department of Health (NYS DoH) as an LDT. Test results are provided via Prometheus Laboratories Inc. to physicians.1
†Beneficiaries of any state or federal health insurance program (including, but not limited to, Medicare, Medicaid, Department of Veterans Affairs, Coast Guard, Public Health Service, or Department of Defense) are excluded from participating in this program.
Takeda will cover the following costs based on blood draw location1‡
(must use shipping label provided in the specimen collection kit)
‡Participating locations for required blood draw include Quest Diagnostic Patient Service Centers, Prometheus-contracted phlebotomy sites, and mobile phlebotomy services. The cost of the blood draw, CDPATH, and shipping will be covered at participating location. Only the cost of CDPATH and blood sample shipping will be covered if the blood draw is completed in a physician's office and it is shipped to the processing laboratory with the provided shipping label.
Patient's blood draw must be performed at a physician's office or participating location.
A patient may incur cost or be turned away if they attempt to obtain a blood draw at a nonparticipating location.
For a list of participating phlebotomy locations in your area, please call CDPATH client services at 1-877-556-8766.
Void where prohibited by law.
Takeda reserves the right to change or end CDPATH at any time without notice, and other terms and conditions may apply.
This test cannot be substituted for or combined with any other test and is only offered for a one-time use.
By using the CDPATH test requisition, you are specially requesting that your patient's specimen be sent to Prometheus for testing and asking that no alternative test be performed.
No insurance claims should be collected or processed, and no charges should be billed to the patient for CDPATH and shipping.
Takeda has made arrangements with the processing laboratory, Prometheus Laboratories Inc., to directly cover these charges.